Joint Pain: Clinical Trials

6 trials for Joint Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 unknown. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 3, Recruiting 2, Unknown 1
Phase 22Recruiting 2

Follow Joint Pain: new trials by email Literature Review of Joint Pain trials Research Report on Joint Pain

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population
Maolactin, Maltodextrin - Chronic Inflammation, Mobility
Phase 3CompletedRDC Clinical Pty Ltd972025-02-272026-11-13
Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation
Celecoxib + Acetaminophen, Celecoxib - Joint Pain, Knee Osteoarthritis
Phase 3CompletedLaboratorios Silanes S.A. de C.V.2312024-09-092026-10-23
The MUSE Study for Menopausal Arthralgia
Menopausal hormone therapy, Exercise training, Menopausal hormone therapy + exercise training - Arthralgia, Menopause
Phase 2 / Phase 3RecruitingNational University Hospital, Singapore1002024-08-012024-07-31
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack
Phase 2 / Phase 3RecruitingOlatec Therapeutics, Inc.3002023-01-062026-03-11
Synvisc Injections for Lumbar Facet Joint Pain
Synvisc viscosupplementation - Joint Pain
Phase 3UnknownSheltering Arms Physical Rehabilitation Hospitals152006-05-012006-09-13
IDEA-033 Open Label Study
IDEA-033 - Joint Pain, Musculoskeletal Pain
Phase 3CompletedIDEA AG4912004-08-012009-03-20

Narrower conditions

Arthralgia (6)  ·  Acute Pain (1)  ·  Arthritis (1)  ·  Arthritis, Gouty (1)  ·  Gout (1)  ·  Hyperuricemia (1)  ·  Inflammation (1)  ·  Motor Activity (1)  ·  Musculoskeletal Pain (1)  ·  Myalgia (1)  ·  Osteoarthritis, Hip (1)  ·  Osteoarthritis, Knee (1)

Broader conditions

Joint Diseases (6)  ·  Musculoskeletal Diseases (6)  ·  Neurologic Manifestations (6)  ·  Pain (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Signs and Symptoms (6)  ·  Muscular Diseases (2)  ·  Rheumatic Diseases (2)  ·  Arthritis (1)  ·  Behavior (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Crystal Arthropathies (1)  ·  Genetic Diseases, Inborn (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)

Interventions

Acetaminophen (1)  ·  CelE protein, bacteria (1)  ·  Celecoxib (1)  ·  Dipeptidyl-Peptidases and Tripeptidyl-Peptidases (1)  ·  Exercise (1)  ·  Hormone Replacement Therapy (1)  ·  dapansutrile (1)  ·  maltodextrin (1)

Sponsors

IDEA AG (1)  ·  Laboratorios Silanes S.A. de C.V. (1)  ·  National University Hospital, Singapore (1)  ·  Olatec Therapeutics, Inc. (1)  ·  RDC Clinical Pty Ltd (1)  ·  Sheltering Arms Physical Rehabilitation Hospitals (1)

Countries

United States (2)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Adelfia Urenda-Quezada, MD (1)  ·  David Briskey, PhD (1)  ·  Ilka Rother (1)  ·  Isabel E Rucker-Joerg, MD (1)  ·  Ivonne A Torres-Quiroz, MD (1)  ·  Martha V Chavira-Flores, MD (1)  ·  Michael J DePalma, MD (1)  ·  Rodrigo Suarez-Otero, MD (1)

NIH funding

2023 (1)